Deferoxamine mesylate
Deferoxamine mesylate Brand names, Deferoxamine mesylate Analogs
Deferoxamine mesylate Brand Names Mixture
- No information avaliable
Deferoxamine mesylate Chemical_Formula
C20H29N3O2
Deferoxamine mesylate RX_link
No information avaliable
Deferoxamine mesylate fda sheet
Deferoxamine mesylate msds (material safety sheet)
Deferoxamine mesylate Synthesis Reference
No information avaliable
Deferoxamine mesylate Molecular Weight
343.463 g/mol
Deferoxamine mesylate Melting Point
99-101oC (HCl salt)
Deferoxamine mesylate H2O Solubility
42 mg/L
Deferoxamine mesylate State
Solid
Deferoxamine mesylate LogP
3.588
Deferoxamine mesylate Dosage Forms
Ointment
Deferoxamine mesylate Indication
For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Deferoxamine mesylate Pharmacology
Dibucaine is an amide-type local anesthetic, similar to lidocaine.
Deferoxamine mesylate Absorption
In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.
Deferoxamine mesylate side effects and Toxicity
Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.
Deferoxamine mesylate Patient Information
No information avaliable
Deferoxamine mesylate Organisms Affected
Humans and other mammals
